Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome

American Journal of Transplantation

Volumn 8, Issue 11, 2008, Pages 2454-2462

  Huang, H J ^a   Yusen, R D ^a   Meyers, B F ^a   Walter, M J ^a   Mohanakumar, T ^a   Patterson, G A ^a   Trulock, E P ^a   Hachem, R R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiolitis obliterans syndrome; Lung transplantation; Primary graft dysfunction

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE GRAFT REJECTION; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAFT DYSFUNCTION; HUMAN; LUNG GRAFT REJECTION; LYMPHOCYTIC BRONCHITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; VIRAL RESPIRATORY TRACT INFECTION;

BRONCHIOLITIS OBLITERANS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY GRAFT DYSFUNCTION; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 53749096668     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02389.x     Document Type: Article

References (35)

1. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003 167 : 490 511.
2. Christie JD, Van Raemdonck D, de Perrot M et al. Report of the ISHLT working group on primary lung graft dysfunction part I: Introduction and methods. J Heart Lung Transplant 2005 24 : 1451 1453.
3. Christie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005 171 : 1312 1316.
4. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005 24 : 1454 1459.
5. Prekker ME, Nath DS, Walker AR et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006 25 : 371 378.
6. Whitson BA, Prekker ME, Herrington CS, Whelan TPM, Radosevich DM, Dahlberg PS. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007 26 : 1004 1011.
7. Whitson BA, Nath DS, Johnson AC et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006 131 : 73 80.
8. Daud SA, Yusen RD, Meyers BF et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007 175 : 507 513.
9. Hachem RR, Khalifah AP, Chakinala MM et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005 80 : 1406 1413.
10. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996 15 : 1 15.
11. Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol 1993 17 : 491 496.
12. Khalifah AP, Hachem RR, Chakinala MM et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004 170 : 181 187.
13. Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993 12 : 713 716.
14. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297 310.
15. Burton CM, Iversen M, Milman N et al. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 2007 31 : 75 82.
16. Bharat A, Narayanan K, Street T et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007 83 : 150 158.
17. Bharat A, Kuo E, Hachem R et al. Immunological link between primary graft dysfunction (PGD) and bronchiolitis obliterans syndrome (BOS) (abstract). Abstract presented at the Annual Meeting of the Society of Thoracic Surgeons, Fort Lauderdale FL, 26-29 January 2008.
18. Mauck KA, Hosenpud JD. The bronchial epithelium: A potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant 1996 15 : 709 714.
19. Waddell TK, Gorczynski RM, DeCampos KN, Patterson GA, Slutsky AS. Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg 1996 662 : 866 872.
20. Smith MA, Sundaresan S, Mohanakumar T et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 1998 116 : 812 820.
21. Palmer SM, Davis RD, Hadjiliadis D et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 2002 74 : 799 804.
22. Girnita AL, Duquesnoy R, Yousem SA et al. HLA-specific antibodies are risk factors for lymphocytic bronchitis and chronic lung allograft dysfunction. Am J Transplant 2005 5 : 131 138.
23. Hachem RR, Yusen RD, Patterson GA, Trulock EP. Impact of primary graft dysfunction on bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2007 26 (S2 109 (abstract).
24. Elidemir O, Doan ML, McKenzie ED, Heinle JS, Morales DL, Mallory GB. Primary graft dysfunction and acute rejection in pediatric lung transplant recipients. Proc Am Thorac Soc 2006 3 : A366 (abstract).
25. Magro CM, Ross P, Kelsey M, Waldman WJ, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant 2003 3 : 115 1166.
26. Jaramillo A, Smith CR, Maruyama T, Zhang L, Patterson GA, Mohanakumar T. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: A possible mechanism for bronchiolitis obliterans syndrome. Human Immunology 2003 64 : 521 529.
27. Madri JA, Furthmayr H. Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Human Pathology 1980 11 : 353 366.
28. van Kuppevelt TH, Veerkamp JH, Timmermans JA. Immunoquantification of type I, III, and V collagen in small samples of human lung parenchyma. Int J Biochem Cell Biol 1995 27 : 775 782.
29. Haque MA, Mizobuchi T, Yasufuku K et al. Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002 169 : 1542 1549.
30. Yoshida S, Haque A, Mizobuchi T et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006 6 : 724 735.
31. Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, Mohanakumar T. CD4 + 25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 2006 6 : 1799 1808.
32. Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T. Induction of IL-10 suppressors in lung transplant patients by CD4 + 25+ regulatory T cells through CTLA-4 signaling. J Immunol 2006 177 : 5631 5638.
33. Goers TA, Ramachandran S, Aloush A, Trulock EP, Patterson GA, Mohanakumar T. De novo production of K-α1 tubulin-specific antibodies: Role in chronic lung allograft rejection. J Immunol 2008 180 : 4487 4494.
34. Hubner RH, Meffert S, Mundt U et al. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 2005 25 : 494 501.
35. Nicod LP. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 2006 3 : 444 449.